Scientists at a UA lab are putting the finishing touches on a new method to detect aggressive bacteria infections 95 percent faster, which could save hospitals around the nation hundreds of thousands ...

The Food and Drug Administration (FDA) has authorized marketing of a new diagnostic test, cobas vivoDx MRSA (Roche Molecular Systems Inc), to detect methicillin-resistant Staphylococcus aureus (MRSA) ...

bioMérieux, French manufacturer of diagnostic solutions, has received FDA 510(k) approval for NucliSENS EasyQ MRSA, an automated molecular test for MRSA, according to a company news release. The test ...

Company Offers Most Comprehensive, Cost-Effective Suite of Solutions to Detect and Screen for Methicillin Resistant Staphylococcus aureus (MRSA) “bioMérieux is committed to bringing innovative ...

The Illinois Department of Public Health announced the publication of the first infection surveillance data on Clostridium difficile and methicillin-resistant Staphylococcus aureus rates from lab ...

The US Food and Drug Administration (FDA) has approved a new, faster diagnostic test based on bacterial viability and a novel technology to detect methicillin-resistant Staphylococcus aureus (MRSA) ...

Easy-to-use molecular test offers faster results to help healthcare facilities control spread of methicillin-resistant Staphylococcus aureus (MRSA) "It is important that healthcare professionals have ...

For the first time, Illinois hospitals have released data on the rates of Clostridium difficile and methicillin-resistant Staphylococcus aureus from lab results. This data is available on the Illinois ...

Detect-Ready assay requires swab DNA and provides results in three hours. Molecular Detection (MDI) appointed Launch Diagnostics as the exclusive distributor for its Detect-Ready™ MRSA assay in the ...

(PeopleImages/Getty Images) A blood pressure drug has the potential to combat one of the most common, difficult-to-treat ...